Advanced Enzyme Technologies Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Advanced Enzyme Technologies.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 20.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07Are Insiders Buying Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stock?
Jul 29How Does Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Fare As A Dividend Stock?
Jul 17Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Jul 04Do Advanced Enzyme Technologies's (NSE:ADVENZYMES) Earnings Warrant Your Attention?
Jun 28In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Advanced Enzyme Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 6,048 | 1,371 | N/A | N/A | N/A |
9/30/2023 | 5,859 | 1,248 | 965 | 1,327 | N/A |
6/30/2023 | 5,668 | 1,166 | N/A | N/A | N/A |
3/31/2023 | 5,406 | 1,056 | 1,022 | 1,404 | N/A |
12/31/2022 | 5,337 | 979 | N/A | N/A | N/A |
9/30/2022 | 5,251 | 960 | 806 | 1,164 | N/A |
6/30/2022 | 5,135 | 995 | N/A | N/A | N/A |
3/31/2022 | 5,294 | 1,196 | 941 | 1,223 | N/A |
12/31/2021 | 5,309 | 1,268 | N/A | N/A | N/A |
9/30/2021 | 5,350 | 1,424 | 1,127 | 1,374 | N/A |
6/30/2021 | 5,325 | 1,500 | N/A | N/A | N/A |
3/31/2021 | 5,018 | 1,459 | 1,434 | 1,630 | N/A |
12/31/2020 | 4,820 | 1,459 | N/A | N/A | N/A |
9/30/2020 | 4,569 | 1,364 | 978 | 1,472 | N/A |
6/30/2020 | 4,481 | 1,301 | N/A | N/A | N/A |
3/31/2020 | 4,440 | 1,293 | 904 | 1,409 | N/A |
12/31/2019 | 4,480 | 1,302 | N/A | N/A | N/A |
9/30/2019 | 4,366 | 1,210 | 1,147 | 1,276 | N/A |
6/30/2019 | 4,288 | 1,148 | N/A | N/A | N/A |
3/31/2019 | 4,220 | 1,111 | 1,162 | 1,286 | N/A |
12/31/2018 | 4,194 | 1,061 | N/A | N/A | N/A |
9/30/2018 | 4,261 | 1,068 | N/A | N/A | N/A |
6/30/2018 | 4,199 | 1,039 | N/A | N/A | N/A |
3/31/2018 | 3,918 | 901 | 1,050 | 1,160 | N/A |
12/31/2017 | 3,660 | 837 | N/A | N/A | N/A |
9/30/2017 | 3,213 | 725 | N/A | N/A | N/A |
6/30/2017 | 3,127 | 793 | N/A | N/A | N/A |
3/31/2017 | 3,290 | 915 | N/A | 1,074 | N/A |
12/31/2016 | 3,260 | 942 | N/A | N/A | N/A |
9/30/2016 | 3,404 | 998 | N/A | N/A | N/A |
6/30/2016 | 3,184 | 854 | N/A | N/A | N/A |
3/31/2016 | 2,938 | 759 | N/A | 934 | N/A |
3/31/2015 | 2,233 | 510 | N/A | 537 | N/A |
3/31/2014 | 2,397 | 201 | N/A | 433 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ADVENZYMES's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if ADVENZYMES's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if ADVENZYMES's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ADVENZYMES's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if ADVENZYMES's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ADVENZYMES's Return on Equity is forecast to be high in 3 years time